Jpmorgan Chase & CO Medtronic PLC Transaction History

Jpmorgan Chase & CO

$1.23 Trillion
Q4 2024

A detailed history of Jpmorgan Chase & CO transactions in Medtronic PLC stock. As of the latest transaction made, Jpmorgan Chase & CO holds 34,425,599 shares of MDT stock, worth $3.03 Billion. This represents 0.22% of its overall portfolio holdings.

Number of Shares

34,425,599

Previous 30,739,926 11.99%

Holding current value

$3.03 Billion

Previous $2.77 Billion 0.64%

% of portfolio

0.22%

Previous 0.23%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$79.61 - $92.24 $293 Million - $340 Million	3,685,673 Added 11.99%	34,425,599 $2.75 Billion
Q3 2024 Dec 26, 2024	BUY	$76.84 - $91.03 $167 Million - $198 Million	2,174,873 Added 7.61%	30,739,926 $2.77 Billion
Q3 2024 Nov 08, 2024	BUY	$76.84 - $91.03 $114 Million - $135 Million	1,479,553 Added 5.18%	30,044,606 $2.7 Billion
Q2 2024 Dec 26, 2024	SELL	$78.71 - $87.02 $116 Million - $129 Million	-1,479,553 Reduced 4.92%	28,565,053 $2.25 Billion
Q2 2024 Aug 12, 2024	SELL	$78.71 - $87.02 $241 Million - $266 Million	-3,061,843 Reduced 9.68%	28,565,053 $2.25 Billion
Q1 2024 Dec 26, 2024	BUY	$82.84 - $88.09 $131 Million - $139 Million	1,582,290 Added 5.27%	31,626,896 $2.76 Billion
Q1 2024 May 10, 2024	BUY	$82.84 - $88.09 $517 Million - $550 Million	6,241,759 Added 24.59%	31,626,896 $2.76 Billion
Q4 2023 Dec 26, 2024	SELL	$69.43 - $83.43 $324 Million - $389 Million	-4,659,469 Reduced 15.51%	25,385,137 $2.09 Billion
Q4 2023 Feb 12, 2024	BUY	$69.43 - $83.43 $383 Million - $461 Million	5,522,685 Added 27.8%	25,385,137 $2.09 Billion
Q3 2023 Nov 14, 2023	BUY	$78.22 - $90.4 $16.7 Million - $19.3 Million	213,271 Added 1.09%	19,862,452 $1.56 Billion
Q2 2023 Aug 11, 2023	SELL	$79.47 - $91.38 $55.7 Million - $64 Million	-700,802 Reduced 3.44%	19,649,181 $1.73 Billion
Q1 2023 May 18, 2023	BUY	$76.72 - $87.58 $48 Million - $54.8 Million	626,051 Added 3.17%	20,349,983 $1.64 Billion
Q1 2023 May 11, 2023	SELL	$76.72 - $87.58 $22.9 Million - $26.1 Million	-298,314 Reduced 1.49%	19,723,932 $1.59 Billion
Q4 2022 Feb 13, 2023	SELL	$76.18 - $87.74 $84.5 Million - $97.3 Million	-1,109,473 Reduced 5.25%	20,022,246 $1.56 Billion
Q3 2022 Nov 14, 2022	BUY	$80.75 - $95.31 $299 Million - $353 Million	3,708,132 Added 21.28%	21,131,719 $1.71 Billion
Q2 2022 Aug 11, 2022	SELL	$87.4 - $113.09 $126 Million - $163 Million	-1,437,047 Reduced 7.62%	17,423,587 $1.56 Billion
Q1 2022 May 11, 2022	SELL	$100.58 - $112.38 $43.6 Million - $48.8 Million	-433,883 Reduced 2.25%	18,860,634 $2.09 Billion
Q4 2021 Feb 10, 2022	SELL	$99.53 - $127.75 $458 Million - $588 Million	-4,600,966 Reduced 19.25%	19,294,517 $2 Billion
Q3 2021 Nov 12, 2021	BUY	$122.75 - $135.17 $2.93 Billion - $3.23 Billion	23,895,483 New	23,895,483 $3 Billion

Others Institutions Holding MDT

# of Institutions

2,348

Shares Held

1.05B

Call Options Held

Put Options Held

7.22M

View Full List

About Medtronic plc

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $117B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

More about MDT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Medtronic PLC Transaction History